Insider Purchase by Redmile Group, LLC (10% Owner)
Trade Summary
1 month ago, Redmile Group, LLC, serving as 10% owner Owner at Attovia Therapeutics, Inc. (ATTO), purchased 600,000 shares at $17.00 per share, for a total transaction value of $10,200,000.00. Following this transaction, Redmile Group, LLC now holds 1,182,854 shares of ATTO.
This purchase represents a 102.94% increase in Redmile Group, LLC's stake in the company. This is considered a high-conviction trade given the significant change in ownership.
The trade was executed on Thursday, August 6, 2026 and publicly disclosed via SEC Form 4 filing on Saturday, August 8, 2026 (accepted Aug 7, 9:47 PM ET), 2 days after the trade was made.
Attovia Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.
Trade Price
$17.00
Quantity
600,000
Total Value
$10,200,000.00
Shares Owned
1,182,854
Trade Date
50 days ago
SEC Filing Date
(accepted Aug 7, 9:47 PM ET)
Filed 2 days after trade
Discussion